Dark Forest Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,736
Closed -$2.88M 811
2026
Q1
$2.88M Buy
+15,736
New +$2.9M 0.26% 96
2024
Q4
Sell
-2,797
Closed -$542K 950
2024
Q3
$542K Buy
+2,797
New +$585K 0.07% 351
2022
Q4
Sell
-42
Closed -$11K 1157
2022
Q3
$11K Buy
+42
New +$8.92K ﹤0.01% 719
2022
Q2
Sell
-15
Closed -$3K 910
2022
Q1
$3K Sell
15
-8
-35% -$1.74K ﹤0.01% 1144
2021
Q4
$6K Buy
+23
New +$5.91K ﹤0.01% 1083

Other funds holding BIIB

Dark Forest Capital Management's BIIB Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Biogen (BIIB) in Q2 2026, closing a stake of 15,736 shares — an estimated $2.88M sold.

Dark Forest Capital Management first reported a position in BIIB in Q4 2021 and held it in 5 quarters. The position peaked at $2.88M in Q1 2026. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Dark Forest Capital Management reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 15,736 Biogen shares in Q2 2026, an estimated $2.88M.
  • Dark Forest Capital Management first reported a position in Biogen in Q4 2021 and held it in 5 quarters.
  • Dark Forest Capital Management's Biogen position peaked at $2.88M in Q1 2026.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.